FDA alerts public about treatments with similar names

12/28/2011 | Reuters

A mix-up between steroidal eye drop Durezol and wart remover Durasal caused serious harm to a patient, according to an FDA warning. Elorac, which distributes Durasal, has not responded to the FDA's request for market withdrawal of the unapproved product, the agency said.

View Full Article in:


Published in Briefs: